Cell lines provide a critical foundation in studies to identify and understand the underlying mechanisms of diseases such as cancer. However, the use of misidentified cell lines and inaccurate public datasets can adversely affect biomedical research and development. For scientists to make insightful correlations that can translate to the development of life-saving therapeutics, it is essential that they start with high-quality, authenticated biological materials backed by curated, accurate 'omics data.